Dapagliflozin Reduces Ambulatory Arterial Stiffness Index in CKD Patients with and Without Diabetes Independently of Blood Pressure Control: Results from the GLUcose Transport and Renal PROtection in Chronic Kidney Disease (GLUTREPRO) Trial

High Blood Pressure and Cardiovascular Prevention · Published 2025-12-09 · DOI 10.1007/s40292-025-00764-3

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1007/s40292-025-00764-3

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2025

Related articles